See more : Lifeist Wellness Inc. (LFST.V) Income Statement Analysis – Financial Results
Complete financial analysis of Senseonics Holdings, Inc. (SENS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Senseonics Holdings, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Doman Building Materials Group Ltd. (CWXZF) Income Statement Analysis – Financial Results
- Welbe, Inc. (6556.T) Income Statement Analysis – Financial Results
- Walgreens Boots Alliance, Inc. (0LSZ.L) Income Statement Analysis – Financial Results
- NuGenerex Immuno-Oncology, Inc. (NUGX) Income Statement Analysis – Financial Results
- EPL Limited (EPL.NS) Income Statement Analysis – Financial Results
Senseonics Holdings, Inc. (SENS)
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.39M | 16.39M | 13.68M | 4.95M | 21.30M | 18.91M | 6.37M | 332.00K | 38.00K | 0.00 | 17.00K |
| Cost of Revenue | 19.30M | 13.66M | 14.49M | 22.32M | 40.75M | 27.06M | 9.76M | 660.00K | 118.00K | 0.00 | 5.00K |
| Gross Profit | 3.09M | 2.73M | -811.00K | -17.37M | -19.45M | -8.15M | -3.39M | -328.00K | -80.00K | 0.00 | 12.00K |
| Gross Profit Ratio | 13.81% | 16.63% | -5.93% | -350.90% | -91.30% | -43.07% | -53.11% | -98.80% | -210.53% | 0.00% | 70.59% |
| Research & Development | 48.75M | 39.72M | 27.22M | 20.41M | 38.43M | 31.86M | 30.74M | 26.35M | 18.25M | 12.88M | 13.79M |
| General & Administrative | 0.00 | 0.00 | 21.54M | 20.80M | 23.23M | 19.84M | 15.34M | 13.02M | 9.81M | 5.73M | 5.01M |
| Selling & Marketing | 0.00 | 0.00 | 7.62M | 20.55M | 49.56M | 27.73M | 6.86M | 2.74M | 792.00K | 95.00K | 0.00 |
| SG&A | 29.94M | 31.63M | 29.15M | 41.35M | 72.78M | 47.57M | 22.19M | 15.76M | 10.60M | 5.82M | 5.01M |
| Other Expenses | 0.00 | -102.00K | -174.00K | -311.00K | -511.00K | -321.00K | 176.00K | 25.00K | 26.00K | 0.00 | 0.00 |
| Operating Expenses | 78.69M | 71.35M | 56.37M | 61.76M | 111.21M | 79.43M | 52.93M | 42.11M | 28.85M | 18.70M | 18.80M |
| Cost & Expenses | 97.99M | 85.02M | 70.86M | 84.08M | 151.96M | 106.49M | 62.69M | 42.77M | 28.85M | 18.70M | 18.81M |
| Interest Income | 5.36M | 1.82M | 243.00K | 175.00K | 1.93M | 2.00M | 135.00K | 80.00K | 9.00K | 0.00 | 10.00K |
| Interest Expense | 11.11M | 18.70M | 16.72M | 16.17M | 12.20M | 8.28M | 3.10M | 1.60M | 1.10M | 191.00K | 0.00 |
| Depreciation & Amortization | 1.28M | 985.00K | 1.24M | 1.14M | 1.00M | 270.00K | 227.27K | 155.00K | 118.00K | 189.00K | 220.00K |
| EBITDA | -48.01M | 161.81M | -284.52M | -157.86M | -99.41M | -85.42M | -55.77M | -42.17M | -28.66M | -18.51M | -18.57M |
| EBITDA Ratio | -214.40% | -408.23% | -417.65% | -1,859.91% | -622.43% | -454.17% | -875.18% | -12,702.71% | -75,418.42% | 0.00% | -109,229.41% |
| Operating Income | -75.60M | -68.63M | -57.18M | -79.13M | -130.66M | -87.58M | -56.31M | -42.43M | -28.81M | -18.70M | -18.79M |
| Operating Income Ratio | -337.66% | -418.74% | -418.15% | -1,598.91% | -613.41% | -463.06% | -883.62% | -12,781.02% | -75,821.05% | 0.00% | -110,523.53% |
| Total Other Income/Expenses | 15.21M | 210.75M | -245.29M | -96.04M | 15.11M | -6.39M | -2.79M | -1.50M | -1.07M | -183.00K | 10.00K |
| Income Before Tax | -60.39M | 142.12M | -302.48M | -175.17M | -115.55M | -93.97M | -59.10M | -43.93M | -29.88M | -18.89M | -18.78M |
| Income Before Tax Ratio | -269.73% | 867.16% | -2,211.88% | -3,539.46% | -542.46% | -496.86% | -927.37% | -13,231.93% | -78,623.68% | 0.00% | -110,464.71% |
| Income Tax Expense | 0.00 | 18.70M | 15.31M | 15.86M | 10.69M | 6.39M | 2.79M | 1.50M | 1.07M | 183.00K | 0.00 |
| Net Income | -60.39M | 142.12M | -317.78M | -191.02M | -126.23M | -93.97M | -59.10M | -43.93M | -29.88M | -18.89M | -18.78M |
| Net Income Ratio | -269.73% | 867.16% | -2,323.81% | -3,859.85% | -592.62% | -496.86% | -927.37% | -13,231.93% | -78,623.68% | 0.00% | -110,464.71% |
| EPS | -0.11 | 0.30 | -0.75 | -0.84 | -0.67 | -0.60 | -0.51 | -0.49 | -0.33 | -9.89 | -24.66 |
| EPS Diluted | -0.11 | -0.11 | -0.75 | -0.84 | -0.67 | -0.60 | -0.51 | -0.49 | -0.33 | -9.89 | -24.66 |
| Weighted Avg Shares Out | 567.97M | 467.95M | 422.32M | 227.91M | 188.75M | 157.43M | 115.98M | 89.24M | 91.56M | 1.91M | 761.63K |
| Weighted Avg Shares Out (Dil) | 567.97M | 618.21M | 422.32M | 227.91M | 188.75M | 157.43M | 115.98M | 89.24M | 91.56M | 1.91M | 761.63K |
Senseonics Holdings, Inc. (SENS) Q3 2022 Earnings Call Transcript
Senseonics Holdings, Inc. (NYSE:SENS ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Philip Taylor – Investor Relations Tim Goodnow – President and Chief Executive Officer Rick Sullivan – Chief Financial Officer Conference Call Participants...
Penny Stocks To Buy: 4 Stocks Under $5 To Watch This Week
Hot penny stocks to buy for under $5 but are they worth the risk? The post Penny Stocks To Buy: 4 Stocks Under $5 To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information |...
Senseonics Holdings: Planning To Increase Revenue After FDA System Approval
The partnership between Senseonics Holdings and Elevance Health (formerly Anthem) is expected to increase coverage to Senseonics' implantable CGM systems including Eversense. Senseonics plans to introduce new diabetes management systems as well as doctors and patients to the Eversense E3...
Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin...
Senseonics (SENS) Q2 2022 Earnings Highlights
Senseonics (SENS) recently announced its Q2 2022 financial results. These are the details.
Senseonics Holdings, Inc. (SENS) CEO Tim Goodnow on Q2 2022 Results - Earnings Call Transcript
Senseonics Holdings, Inc. (NYSE:SENS ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Philip Taylor - Investor Relations Tim Goodnow - President and Chief Executive Officer Nick Tressler - Financial Officer Mukul Jain - Chief...
Why Is Senseonics (SENS) Stock Heating Up Today?
Senseonics (NYSEAMERICAN: SENS ) stock jumped by over 50% after it announced its Eversense implantable glucose monitor was approved for coverage by Elevance Health (NYSE: ELV ), formerly known as Anthem. Senseonics had revenue of just $2.5 million in the...
Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its second quarter...
Which Industries Are Penny Stocks Investors Watching Right Now
Use these tips for finding penny stocks in different industries in 2022 The post Which Industries Are Penny Stocks Investors Watching Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
7 Undervalued Penny Stocks to Buy for Massive Gains
These seven undervalued penny stocks each have the potential to pay off for investors down later down the road. The post 7 Undervalued Penny Stocks to Buy for Massive Gains appeared first on InvestorPlace.
Source: https://incomestatements.info
Category: Stock Reports